Trial of Efficacy and Safety of MC0518 Versus Best Available Therapy in Participants With Steroid-Refractory Acute Graft Versus Host Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
The purpose of this trial is the comparative evaluation of overall response rate (ORR) in paediatric participants with steroid-refractory acute graft-versus-host disease (SR-aGvHD) at Visit Day 28 after treatment with MC0518 or first used best available therapy (BAT).
Epistemonikos ID: afe1d754e1ae3ff134a901a5eb78d7eb36296b40
First added on: May 15, 2024